Thermo Fisher Scientific Inc. (TMO) stock
TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 10/3028% above fair value
$686.79−4.54 (-0.66%)
Close on Nov 17, 2026Market cap $254.47BP/E 36.2Yield 0.25%
Thermo Fisher Scientific operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Thermo Fisher Scientific's operating income for the twelve months ending Sep 26, 2026 was $8.47B, up 12.8% year over year. For fiscal 2025 it was $7.75B, up 5.6% from the year before. Over ten years it grew 12.7% a year on average. The highest annual figure on record is $10.03B in fiscal 2021.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.75B | +5.6% |
| FY2024 | Dec 31, 2024 | $7.34B | +7.0% |
| FY2023 | Dec 31, 2023 | $6.86B | -18.3% |
| FY2022 | Dec 31, 2022 | $8.39B | -16.3% |
| FY2021 | Dec 31, 2021 | $10.03B | +28.7% |
| FY2020 | Dec 31, 2020 | $7.79B | +69.7% |
| FY2019 | Dec 31, 2019 | $4.59B | +21.4% |
| FY2018 | Dec 31, 2018 | $3.78B | +27.8% |
| FY2017 | Dec 31, 2017 | $2.96B | +20.4% |
| FY2016 | Dec 31, 2016 | $2.46B | +5.2% |
| FY2015 | Dec 31, 2015 | $2.34B | -6.7% |
| FY2014 | Dec 31, 2014 | $2.50B | +55.5% |
| FY2013 | Dec 31, 2013 | $1.61B | +8.6% |
| FY2012 | Dec 31, 2012 | $1.48B | +18.5% |
| FY2011 | Dec 31, 2011 | $1.25B | +5.3% |
| FY2010 | Dec 31, 2010 | $1.19B | +18.6% |
| FY2009 | Dec 31, 2009 | $1.00B | -18.5% |
| FY2008 | Dec 31, 2008 | $1.23B | +26.2% |
| FY2007 | Dec 31, 2007 | $974.40M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 26, 2026 | $2.26B | +16.6% |
| Q2 FY2026 | Jun 27, 2026 | $2.09B | +13.8% |
| Q1 FY2026 | Mar 28, 2026 | $1.86B | +8.6% |
| Q4 FY2025 | Dec 31, 2025 | $2.26B | +11.9% |
| Q3 FY2025 | Sep 27, 2025 | $1.94B | +5.6% |
| Q2 FY2025 | Jun 28, 2025 | $1.83B | +0.8% |
| Q1 FY2025 | Mar 29, 2025 | $1.72B | +3.2% |
| Q4 FY2024 | Dec 31, 2024 | $2.02B | +8.7% |
| Q3 FY2024 | Sep 28, 2024 | $1.84B | -1.4% |
| Q2 FY2024 | Jun 29, 2024 | $1.82B | +15.3% |
| Q1 FY2024 | Mar 30, 2024 | $1.66B | +6.4% |
| Q4 FY2023 | Dec 31, 2023 | $1.85B | -0.4% |
| Q3 FY2023 | Sep 30, 2023 | $1.86B | +9.0% |
| Q2 FY2023 | Jul 1, 2023 | $1.58B | -21.1% |
| Q1 FY2023 | Apr 1, 2023 | $1.56B | -44.6% |
| Q4 FY2022 | Dec 31, 2022 | $1.86B | -26.7% |
| Q3 FY2022 | Oct 1, 2022 | $1.71B | -24.9% |
| Q2 FY2022 | Jul 2, 2022 | $2.00B | -7.5% |
| Q1 FY2022 | Apr 2, 2022 | $2.82B | -7.5% |
| Q4 FY2021 | Dec 31, 2021 | $2.54B | -17.4% |
| Q3 FY2021 | Oct 2, 2021 | $2.28B | -6.1% |
| Q2 FY2021 | Jul 3, 2021 | $2.16B | +55.5% |
| Q1 FY2021 | Apr 3, 2021 | $3.05B | +236.5% |
| Q4 FY2020 | Dec 31, 2020 | $3.07B | +149.3% |
| Q3 FY2020 | Sep 26, 2020 | $2.43B | +156.4% |
| Q2 FY2020 | Jun 27, 2020 | $1.39B | -7.0% |
| Q1 FY2020 | Mar 28, 2020 | $906.00M | -1.5% |
| Q4 FY2019 | Dec 31, 2019 | $1.23B | +7.3% |
| Q3 FY2019 | Sep 28, 2019 | $946.00M | +3.7% |
| Q2 FY2019 | Jun 29, 2019 | $1.50B | +59.7% |
| Q1 FY2019 | Mar 30, 2019 | $920.00M | +17.0% |
| Q4 FY2018 | Dec 31, 2018 | $1.15B | +20.0% |
| Q3 FY2018 | Sep 29, 2018 | $912.00M | +43.8% |
| Q2 FY2018 | Jun 30, 2018 | $937.00M | +25.1% |
| Q1 FY2018 | Mar 31, 2018 | $786.00M | +26.8% |
| Q4 FY2017 | Dec 31, 2017 | $957.00M | +25.7% |
| Q3 FY2017 | Sep 30, 2017 | $634.00M | – |
| Q2 FY2017 | Jul 1, 2017 | $749.00M | – |
| Q1 FY2017 | Apr 1, 2017 | $620.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $761.40M | – |
See a number that looks wrong?